Destiny Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,938
Closed -$389K 459
2026
Q1
$389K Hold
1,938
0.04% 160
2025
Q4
$426K Hold
1,938
0.05% 141
2025
Q3
$347K Hold
1,938
0.04% 153
2025
Q2
$313K Hold
1,938
0.04% 153
2025
Q1
$330K Hold
1,938
0.05% 129
2024
Q4
$322K Hold
1,938
0.05% 130
2024
Q3
$333K Hold
1,938
0.06% 122
2024
Q2
$298K Hold
1,938
0.05% 122
2024
Q1
$298K Hold
1,938
0.05% 126
2023
Q4
$307K Hold
1,938
0.06% 128
2023
Q3
$284K Hold
1,938
0.06% 139
2023
Q2
$306K Hold
1,938
0.06% 133
2023
Q1
$300K Hold
1,938
0.06% 133
2022
Q4
$299K Hold
1,938
0.06% 157
2022
Q3
$256K Hold
1,938
0.06% 164
2022
Q2
$263K Hold
1,938
0.06% 133
2022
Q1
$289K Sell
1,938
-420
-18% -$62.1K 0.06% 136
2021
Q4
$382K Hold
2,358
0.07% 124
2021
Q3
$392K Sell
2,358
-472
-17% -$80.6K 0.08% 117
2021
Q2
$489K Hold
2,830
0.09% 119
2021
Q1
$454K Buy
+2,830
New +$485K 0.09% 109

Other funds holding FBT

Destiny Wealth Partners's FBT Position: Q2 2026 in Review

Destiny Wealth Partners sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 1,938 shares — an estimated $389K sold.

Destiny Wealth Partners first reported a position in FBT in Q1 2021 and held it in 21 quarters. The position peaked at $489K in Q2 2021. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Destiny Wealth Partners reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
  • Destiny Wealth Partners sold 1,938 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $389K.
  • Destiny Wealth Partners first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2021 and held it in 21 quarters.
  • Destiny Wealth Partners's First Trust NYSE Arca Biotechnology Index Fund position peaked at $489K in Q2 2021.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.